×

Method and Apparatus for Automatically, Identifying and Counting Various Cells in Body Fluids

  • US 3,864,571 A
  • Filed: 02/10/1971
  • Issued: 02/04/1975
  • Est. Priority Date: 02/10/1971
  • Status: Expired due to Term
First Claim
Patent Images

1. The process of differentiating leukocytes in a sample of body fluid comprising the steps of:

  • a. Obtaining at least a one cubic millimeter sample of the body fluid;

    b. Treating said sample with a fluorochrome material that will cause radiation of a characteristic wavelength to be emitted from at least one of the sub-cellular materials when subjected to radiation in the range of 0.30 to 30 microns;

    c. Initiating relative movement between the sample and a radiation source which has at least one associated co-planar radiation detection means;

    d. Continuing the relative motion until the complete sample has passed the radiation source and the at least one co-planar radiation detector in a manner so that the leukocytes in a substantial portion of the sample are in a single cellular array as they pass said plane;

    e. Causing said radiation source to irradiate the sample as the leukocytes pass in said single cellular array;

    f. Measuring the overall cell sizes of the cells passing said plane by detecting the initiation of the secondary fluorescent emissions with said radiation detection means and continuing said detection until each cell has passed said plane;

    g. Simultaneously determining the amount of each sub-cellular material present in each cell as it passes said plane by detecting the characteristic radiations being emitted by each sub-cellular material in each cell;

    h. Feeding these determinations for each cell as it passes said plane to a logic means wherein the cell is identified on the basis of total cell size and the relative amounts of subcellular material present;

    i. Causing a separate counter for each type of leukocyte to be advanced when a leukocyte of that type is identified by steps;

    j. Repeating steps (e) to (i) to until substantially all of the leukocytes is said sample have passed said plane and have been identified.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×